US ‘Red Tape’ Bill Again Targets Biosimilar Interchangeability – Will It Succeed This Time?

AAM And Biosimilars Council Support Making All Biosimilars Interchangeable

After multiple past attempts, US legislators have once again proposed a bill that would make all biosimilars immediately interchangeable upon approval. Could a fresh political context help it to succeed this time?

The bill has been mooted multiple times in the past (Shutterstock)

More from Biosimilars

More from Policy & Regulation